T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity

Immunology

Volumn 126, Issue 2, 2009, Pages 165-176

  Stone, Jennifer D ^a   Chervin, Adam S ^a   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Agonists; Antagonists; Binding affinity; Coreceptors; Dissociation rate; Major histocompatibility complex; Peptide specificity; Peptide major histocompatibility complex; Serial triggering; T cell receptor; T cell receptor clustering

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL PROLIFERATION; DISSOCIATION; GLYCOSYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TITRIMETRY;

EPITOPES, T-LYMPHOCYTE; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 58149280299     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.03015.x     Document Type: Review

References (106)

1. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006 24 : 419 66.
2. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 1998 16 : 523 44.
3. Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, Schneck JP, Margulies DH, Pardoll DM. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity 2000 13 : 529 38.
4. Boulter JM, Schmitz N, Sewell AK, Godkin AJ, Bachmann MF, Gallimore AM. Potent T cell agonism mediated by a very rapid TCR/pMHC interaction. Eur J Immunol 2007 37 : 798 806.
5. Garcia KC, Tallquist MD, Pease LR et al. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci USA 1997 94 : 13838 43.
6. Alam SM, Davies GM, Lin CM et al. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 1999 10 : 227 37.
7. Rosette C, Werlen G, Daniels MA et al. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 2001 15 : 59 70.
8. Jones LL, Colf LA, Stone JD, Garcia KC, Kranz DM. Distinct CDR3 conformations in T cell receptors determine the level of cross-reactivity for diverse antigens, but not the docking orientation. J Immunol 2008 181 : 6255 64.
9. Buslepp J, Kerry SE, Loftus D, Frelinger JA, Appella E, Collins EJ. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC. J Immunol 2003 170 : 373 83.
10. Davis-Harrison RL, Armstrong KM, Baker BM. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J Mol Biol 2005 346 : 533 50.
11. Lee JK, Stewart-Jones G, Dong T et al. T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med 2004 200 : 1455 66.
12. Cole DK, Pumphrey NJ, Boulter JM et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol 2007 178 : 5727 34.
13. Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael AJ, Jones EY. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 2008 28 : 171 82.
14. Gakamsky DM, Lewitzki E, Grell E, Saulquin X, Malissen B, Montero-Julian F, Bonneville M, Pecht I. Kinetic evidence for a ligand-binding-induced conformational transition in the T cell receptor. Proc Natl Acad Sci USA 2007 104 : 16639 44.
15. Ely LK, Green KJ, Beddoe T et al. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J Immunol 2005 174 : 5593 601.
16. Zhao Y, Bennett AD, Zheng Z et al. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol 2007 179 : 5845 54.
17. Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES. Kinetics and thermodynamics of T cell receptor-autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2001 98 : 6818 23.
18. Kersh GJ, Kersh EN, Fremont DH, Allen PM. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 1998 9 : 817 26.
19. McKeithan TW. Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci USA 1995 92 : 5042 6.
20. Rabinowitz JD, Beeson C, Wulfing C, Tate K, Allen PM, Davis MM, McConnell HM. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 1996 5 : 125 35.
21. Kersh EN, Shaw AS, Allen PM. Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science 1998 281 : 572 5.
22. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995 375 : 148 51.
23. Kalergis AM, Boucheron N, Doucey MA, Palmieri E, Goyarts EC, Vegh Z, Luescher IF, Nathenson SG. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol 2001 2 : 229 34.
24. Carreno LJ, Bueno SM, Bull P, Nathenson SG, Kalergis AM. The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge. Immunology 2007 121 : 227 37.
25. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 2003 18 : 255 64.
26. Li Y, Moysey R, Molloy PE et al. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol 2005 23 : 349 54.
27. Weber KS, Donermeyer DL, Allen PM, Kranz DM. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci USA 2005 102 : 19033 8.
28. Holler PD, Lim AR, Cho BK, Rund LA, Kranz DM. CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J Exp Med 2001 194 : 1043 52.
29. Holler PD, Chlewicki LK, Kranz DM. TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol 2003 4 : 55 62.
30. + T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J Immunol 2007 179 : 2952 60.
31. Krogsgaard M, Prado N, Adams EJ, He XL, Chow DC, Wilson DB, Garcia KC, Davis MM. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell 2003 12 : 1367 78.
32. Armstrong KM, Insaidoo FK, Baker BM. Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. J Mol Recognit 2008 21 : 275 87.
33. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996 274 : 94 6.
34. Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. Embo J 2005 24 : 2968 79.
35. Tissot AC, Pecorari F, Pluckthun A. Characterizing the functionality of recombinant T-cell receptors in vitro: a pMHC tetramer based approach. J Immunol Methods 2000 2 : 147 65.
36. Ogg GS, McMichael AJ. HLA-peptide tetrameric complexes. Curr Opin Immunol 1998 10 : 393 6.
37. Vollers SS, Stern LJ. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 2008 123 : 305 13.
38. Daniels MA, Teixeiro E, Gill J et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 2006 444 : 724 9.
39. Holmberg K, Mariathasan S, Ohteki T, Ohashi PS, Gascoigne NR. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. J Immunol 2003 171 : 2427 34.
40. Perelson AS. Receptor clustering on a cell surface III. Theory of receptor cross-linking by multivalent ligands: description by ligand states. Math Biosci 1981 53 : 1 39.
41. Stone JD, Cochran JR, Stern LJ. T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model. Biophys J 2001 81 : 2547 57.
42. Fahmy TM, Bieler JG, Edidin M, Schneck JP. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 2001 14 : 135 43.
43. Schamel WW, Risueno RM, Minguet S, Ortiz AR, Alarcon B. A conformation- and avidity-based proofreading mechanism for the TCR-CD3 complex. Trends Immunol 2006 27 : 176 82.
44. Wooldridge L, van den Berg HA, Glick M et al. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem 2005 280 : 27491 501.
45. + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J Immunol 2001 166 : 741 5.
46. Naeher D, Daniels MA, Hausmann B, Guillaume P, Luescher I, Palmer E. A constant affinity threshold for T cell tolerance. J Exp Med 2007 204 : 2553 9.
47. Savage PA, Boniface JJ, Davis MM. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 1999 10 : 485 92.
48. Boniface JJ, Rabinowitz JD, Wulfing C et al. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity 1998 9 : 459 66.
49. Cochran JR, Cameron TO, Stern LJ. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 2000 12 : 241 50.
50. Minguet S, Swamy M, Alarcon B, Luescher IF, Schamel WW. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 2007 26 : 43 54.
51. Stone JD, Stern LJ. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement. J Immunol 2006 176 : 1498 505.
52. Kao C, Daniels MA, Jameson SC. Loss of CD8 and TCR binding to class I MHC ligands following T cell activation. Int Immunol 2005 17 : 607 17.
53. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 2002 111 : 967 79.
54. Exley M, Wileman T, Mueller B, Terhorst C. Evidence for multivalent structure of T-cell antigen receptor complex. Mol Immunol 1995 32 : 829 39.
55. Fernandez-Miguel G, Alarcon B, Iglesias A, Bluethmann H, Alvarez-Mon M, Sanz E, de la Hera A. Multivalent structure of an alphabetaT cell receptor. Proc Natl Acad Sci USA 1999 96 : 1547 52.
56. Schamel WW, Arechaga I, Risueno RM, van Santen HM, Cabezas P, Risco C, Valpuesta JM, Alarcon B. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J Exp Med 2005 202 : 493 503.
57. Campi G, Varma R, Dustin ML. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med 2005 202 : 1031 6.
58. Yokosuka T, Sakata-Sogawa K, Kobayashi W, Hiroshima M, Hashimoto-Tane A, Tokunaga M, Dustin ML, Saito T. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol 2005 6 : 1253 62.
59. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 2006 25 : 117 27.
60. Krummel MF, Sjaastad MD, Wulfing C, Davis MM. Differential clustering of CD4 and CD3zeta during T cell recognition. Science 2000 289 : 1349 52.
61. Daniels MA, Devine L, Miller JD et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 2001 15 : 1051 61.
62. Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001 409 : 733 9.
63. Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, Li B. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol 2004 173 : 7200 8.
64. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse: a molecular machine controlling T cell activation. Science 1999 285 : 221 7.
65. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998 395 : 82 6.
66. Dustin ML. T-cell activation through immunological synapses and kinapses. Immunol Rev 2008 221 : 77 89.
67. Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science 2002 295 : 1539 42.
68. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004 5 : 524 30.
69. Cemerski S, Das J, Giurisato E, Markiewicz MA, Allen PM, Chakraborty AK, Shaw AS. The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. Immunity 2008 29 : 414 22.
70. Cemerski S, Das J, Locasale J et al. The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse. Immunity 2007 26 : 345 55.
71. Lee KH, Dinner AR, Tu C et al. The immunological synapse balances T cell receptor signaling and degradation. Science 2003 302 : 1218 22.
72. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM. Direct observation of ligand recognition by T cells. Nature 2002 419 : 845 9.
73. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996 4 : 565 71.
74. Wulfing C, Sumen C, Sjaastad MD, Wu LC, Dustin ML, Davis MM. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat Immunol 2002 3 : 42 7.
75. Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 2005 434 : 238 43.
76. Wang JH, Meijers R, Xiong Y, Liu JH, Sakihama T, Zhang R, Joachimiak A, Reinherz EL. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci USA 2001 98 : 10799 804.
77. Germain RN. T-cell activation: the power of one. Curr Biol 2003 13 : R137 9.
78. Krogsgaard M, Davis MM. How T cells 'see' antigen. Nat Immunol 2005 6 : 239 45.
79. Kern P, Hussey RE, Spoerl R, Reinherz EL, Chang HC. Expression, purification, and functional analysis of murine ectodomain fragments of CD8alphaalpha and CD8alphabeta dimers. J Biol Chem 1999 274 : 27237 43.
80. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA, Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996 384 : 577 81.
81. Gao GF, Willcox BE, Wyer JR et al. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem 2000 275 : 15232 8.
82. Gao GF, Jakobsen BK. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Immunol Today 2000 21 : 630 6.
83. Konig R. Interactions between MHC molecules and co-receptors of the TCR. Curr Opin Immunol 2002 14 : 75 83.
84. Wyer JR, Willcox BE, Gao GF, Gerth UC, Davis SJ, Bell JI, van der Merwe PA, Jakobsen BK. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity 1999 10 : 219 25.
85. Laugel B, van den Berg HA, Gostick E et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem 2007 282 : 23799 810.
86. Potter TA, Bluestone JA, Rajan TV. A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL. J Exp Med 1987 166 : 956 66.
87. Potter TA, Rajan TV, Dick RF II., Bluestone JA. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989 337 : 73 5.
88. Salter RD, Benjamin RJ, Wesley PK et al. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 1990 345 : 41 6.
89. Daniels MA, Jameson SC. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J Exp Med 2000 191 : 335 46.
90. Cho BK, Lian KC, Lee P, Brunmark A, McKinley C, Chen J, Kranz DM, Eisen HN. Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor. Proc Natl Acad Sci USA 2001 98 : 1723 7.
91. + T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 2005 22 : 117 29.
92. Mareeva T, Lebedeva T, Anikeeva N, Manser T, Sykulev Y. Antibody specific for the peptide major histocompatibility complex. Is it T cell receptor-like? J Biol Chem 2004 279 : 44243 9.
93. Yachi PP, Ampudia J, Gascoigne NR, Zal T. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat Immunol 2005 6 : 785 92.
94. Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J. Specificity on a knife-edge: the alphabeta T cell receptor. Curr Opin Struct Biol 2006 16 : 787 95.
95. Manning TC, Kranz DM. Binding energetics of T-cell receptors: correlation with immunological consequences. Immunol Today 1999 20 : 417 22.
96. Donermeyer DL, Weber KS, Kranz DM, Allen PM. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy. J Immunol 2006 177 : 6911 9.
97. Malherbe L, Mark L, Fazilleau N, McHeyzer-Williams LJ, McHeyzer-Williams MG. Vaccine adjuvants alter TCR-based selection thresholds. Immunity 2008 28 : 698 709.
98. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001 2 : 797 801.
99. Kieper WC, Burghardt JT, Surh CD. A role for TCR affinity in regulating naive T cell homeostasis. J Immunol 2004 172 : 40 4.
100. Sercarz EE, Maverakis E. Recognition and function in a degenerate immune system. Mol Immunol 2004 15 : 1003 8.
101. Wucherpfennig KW. T cell receptor crossreactivity as a general property of T cell recognition. Mol Immunol 2004 15 : 1009 17.
102. Wilson DB, Wilson DH, Schroder K, Pinilla C, Blondelle S, Houghten RA, Garcia KC. Specificity and degeneracy of T cells. Mol Immunol 2004 15 : 1047 55.
103. Colf LA, Bankovich AJ, Hanick NA, Bowerman NA, Jones LL, Kranz DM, Garcia KC. How a single T cell receptor recognizes both self and foreign MHC. Cell 2007 129 : 135 46.
104. James LC, Roversi P, Tawfik DS. Antibody multispecificity mediated by conformational diversity. Science 2003 299 : 1362 7.
105. Gakamsky DM, Luescher IF, Pecht I. T cell receptor-ligand interactions: a conformational preequilibrium or an induced fit. Proc Natl Acad Sci USA 2004 101 : 9063 6.
106. Holler PD, Kranz DM. T cell receptors: affinities, cross-reactivities, and a conformer model. Mol Immunol 2004 15 : 1027 31.